These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

595 related items for PubMed ID: 15163501

  • 1. Immunogenicity and protective efficacy of influenza vaccination.
    Hannoun C, Megas F, Piercy J.
    Virus Res; 2004 Jul; 103(1-2):133-8. PubMed ID: 15163501
    [No Abstract] [Full Text] [Related]

  • 2. Impaired response rates, but satisfying protection rates to influenza vaccination in dialysis patients.
    Vogtländer NP, Brown A, Valentijn RM, Rimmelzwaan GF, Osterhaus AD.
    Vaccine; 2004 Jun 02; 22(17-18):2199-201. PubMed ID: 15149777
    [Abstract] [Full Text] [Related]

  • 3. [Immunogenicity and safety of domestic slit influenza vaccine].
    Zhu XJ, Zhang ZL, Li H, Su X, Guo XH, Chen W, Kou M, Duan WP.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jul 02; 25(7):644. PubMed ID: 15308057
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A/H1N1 influenza vaccination in patients with systemic lupus erythematosus: safety and immunity.
    Lu CC, Wang YC, Lai JH, Lee TS, Lin HT, Chang DM.
    Vaccine; 2011 Jan 10; 29(3):444-50. PubMed ID: 21078406
    [Abstract] [Full Text] [Related]

  • 6. [An immunogenicity and reactogenicity study of a purified, inactivated trivalent influenza vaccine for parenteral administration prepared for the 1996-1997 season].
    Lupulescu E, Ioniţă E, Botez D, Matepciuc M, Tabra ME, Tecu C, Alexandrescu V, Munţiu A.
    Bacteriol Virusol Parazitol Epidemiol; 1997 Jan 10; 42(1-2):110-2. PubMed ID: 9235136
    [No Abstract] [Full Text] [Related]

  • 7. Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use.
    Hehme N, Engelmann H, Kuenzel W, Neumeier E, Saenger R.
    Virus Res; 2004 Jul 10; 103(1-2):163-71. PubMed ID: 15163505
    [Abstract] [Full Text] [Related]

  • 8. Virosomal influenza vaccine: a safe and effective influenza vaccine with high efficacy in elderly and subjects with low pre-vaccination antibody titers.
    de Bruijn IA, Nauta J, Gerez L, Palache AM.
    Virus Res; 2004 Jul 10; 103(1-2):139-45. PubMed ID: 15163502
    [Abstract] [Full Text] [Related]

  • 9. Immunity to influenza in older adults with chronic obstructive pulmonary disease.
    Gorse GJ, O'Connor TZ, Newman FK, Mandava MD, Mendelman PM, Wittes J, Peduzzi PN.
    J Infect Dis; 2004 Jul 01; 190(1):11-9. PubMed ID: 15195238
    [Abstract] [Full Text] [Related]

  • 10. The use of inactivated influenza vaccine in children.
    Wright PF.
    Semin Pediatr Infect Dis; 2006 Oct 01; 17(4):200-5. PubMed ID: 17055371
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Influenza vaccination with 1/10th the full dose.
    Cooper CL, Davis H, Cameron DW.
    N Engl J Med; 2004 Nov 25; 351(22):2339-40. PubMed ID: 15564552
    [No Abstract] [Full Text] [Related]

  • 13. National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 1992-93 season.
    Can Commun Dis Rep; 1992 May 29; 18(10):73-8. PubMed ID: 1284383
    [No Abstract] [Full Text] [Related]

  • 14. [Vaccination against influenza in the elderly. Experience with adjuvant vaccines].
    Baldo V, Menegon T, Buoro S, Scalici C, Vesco A, Perale S, Boato W, Carletti M, Bonello C, Dalla Costa D, Trivello R.
    Ann Ig; 1999 May 29; 11(5):369-74. PubMed ID: 10596424
    [No Abstract] [Full Text] [Related]

  • 15. [Preventive influenza vaccination].
    Glathe H.
    Z Arztl Fortbild (Jena); 1990 May 29; 84(8):377-80. PubMed ID: 2378120
    [No Abstract] [Full Text] [Related]

  • 16. [Safety and immunogenicity of split vaccines of influenza viruses].
    Zhu CL, Fang HH, Zhu FC, Wang YQ, Wu XL, Xue FB, Shen YJ, Lian JZ.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Sep 29; 18(3):207-9. PubMed ID: 15640848
    [Abstract] [Full Text] [Related]

  • 17. The safety and efficacy of dose-sparing intradermal administration of influenza vaccine in human immunodeficiency virus-positive patients.
    Khanlou H, Sanchez S, Babaie M, Chien C, Hamwi G, Ricaurte JC, Stein T, Bhatti L, Denouden P, Farthing C.
    Arch Intern Med; 2006 Jul 10; 166(13):1417. PubMed ID: 16832008
    [No Abstract] [Full Text] [Related]

  • 18. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.
    Block SL, Yogev R, Hayden FG, Ambrose CS, Zeng W, Walker RE.
    Vaccine; 2008 Sep 08; 26(38):4940-6. PubMed ID: 18662737
    [Abstract] [Full Text] [Related]

  • 19. National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 1994-95 season.
    Can Commun Dis Rep; 1994 Jun 15; 20(11):85-92. PubMed ID: 7522728
    [No Abstract] [Full Text] [Related]

  • 20. Influenza virus split vaccines. Effect of priming infection on serologic response in humans.
    Niculescu IT, Zilisteanu E, Cretescu L, Matepiuc M, Dumitrescu R, Oprescu E, Bodnar C, Cuteanu I, Vlad A, Mogos A.
    Arch Roum Pathol Exp Microbiol; 1979 Jun 15; 38(2):147-54. PubMed ID: 262510
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.